p53 mutations in L3-loop zinc-binding domain, DNA-ploidy, and S phase fraction are independent prognostic indicators in colorectal cancer: A prospective study with a five-year follow-up

Cancer Epidemiology Biomarkers and Prevention

Volumn 11, Issue 11, 2002, Pages 1322-1331

  Russo, Antonio ^a   Migliavacca, Manuela ^a   Zanna, Ines ^a   Valerio, Maria Rosaria ^c   Latteri, Mario Adelfio ^b   Grassi, Nello ^b   Pantuso, Gianni ^b   Salerno, Sergio ^c   Dardanoni, Gabriella ^f   Albanese, Ida ^e   La Farina, Mario ^e   Tomasino, Rosa Maria ^d   Gebbia, Nicola ^c   Bazan, Viviana ^a  

^a Sections of Molecular Oncology   (Italy)

^b Sections of Surgical Oncology   (Italy)

^c Sections of Medical Oncology   (Italy)

^d Institute of Pathology   (Italy)

^e Department of Cellular and Development Biology ^*  (Italy)

^f UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN P53;

ADULT; AGED; ALPHA HELIX; ANEUPLOIDY; ARTICLE; CANCER STAGING; CELL CYCLE S PHASE; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PLOIDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DOMAIN; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM;

AGED; CARRIER PROTEINS; CODON; COLORECTAL NEOPLASMS; DNA, NEOPLASM; EXONS; FEMALE; FOLLOW-UP STUDIES; GENES, P53; HUMANS; ITALY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; PLOIDIES; POLYMORPHISM, GENETIC; PROGNOSIS; PROSPECTIVE STUDIES; PROTEIN STRUCTURE, TERTIARY; S PHASE; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0036845541     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Arends, J. W. Molecular interactions in the Vogelstein model of colorectal carcinoma. J. Pathol., 190: 412-416, 2000
2. Cosimelli, M., D'Agnano, I., Tedesco, M., D'Angelo, C., Botti, C., Giannarelli, D., Vasselli, S., Cavaliere, F., Zupi, G., and Cavaliere, R. The role of multiploidy as unfavourable prognostic variable in colorectal cancer. Anticancer Res., 18: 1957-1965, 1998
3. Buglioni, S., D'Agnano, I., Vasselli, S., Perrone Donnorso, R., D'Angelo, C., Brenna, A., Benevolo, M., Cosimelli, M., Zupi, G., and Mottolese, M. p53 nuclear accumulation and multiploidy are adverse prognostic factors in surgically resected stage II colorectal cancers independent of fluorouracil-based adjuvant therapy. Am. J. Clin. Pathol., 116: 360-368, 2001
4. Silvestrini, R. Relevance of DNA-ploidy as a prognostic instrument for solid tumors. Ann. Oncol., 11: 259-261, 2000
5. Daidone, M. G., Costa, A., and Silvestrini, R. Cell proliferation markers in human solid tumors: Assessing their impact in clinical oncology. Methods Cell Biol., 64: 359-384, 2001
6. Mc Leod, H. L., and Murray, G. I. Tumour markers of prognosis in colorectal cancer. Br. J. Cancer, 79: 191-203, 1999
7. van Oijen, M. G., and Slootweg, P. J. Gain-of-function mutations in the tumor suppressor gene p53. Clin. Cancer Res., 6: 2138-2145, 2000
8. Prives, C., and Hall, P. A. The p53 pathway. J. Pathol., 187: 112-126, 1999
9. Cho, Y., Gorina, S., Jeffrey, P. D., and Pavletich, N. P. Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations. Science (Wash. DC), 265: 346-355, 1994
10. Kressner, U., Inganas, M., Byding, S., Blikstad, I., Pahlman, L., Glimelius, B., and Lindmark, G. Prognostic value of p53 genetic change in colorectal cancer. J. Clin. Oncol., 17: 593-599, 1999
11. Tortola, S., Marcuello, E., Gonzalez, I., Reyes, G., Arribas, R., Aiza, G., Sancho, F. J., Peinado, M. A., and Capella, G. p53 and K-ras gene mutations correlate with tumor aggressiveness but are not of routine prognostic value in colorectal cancer. J Clin. Oncol., 17: 1375-1381, 1999
12. Borresen-Dale, A., Lothe, R. A., Meling, G. I., Hainaut, P., Rognum, T. O., and Skovlund, E. TP53 and long term prognosis in colorectal cancer: Mutations in the L3 Zinc-binding domain predict poor survival. C[in. Cancer Res., 4: 203-210, 1998
13. Goh, H., Chan, C., Khine, K., and Smith, D. R. p53 and behaviour of colorectal cancer. Lancet, 344: 233-234, 1994
14. Aas, T., Borresen, A., Geisler, S., Smith-Sorensen, B., Johnsen, H., Varhaug, J. E., Akslen, L. A., and Lonning, P. E. Specific p53 mutations are associated with de novo resistence to doxorubicin in breast cancer patients. Nat. Med., 2: 811-813, 1996
15. Skaug, V., Ryberg, D., Kure, E. H., Arab, M. O., Stangeland, L., Myking, A. O., and Haugen, A. P53 mutations in defined structural and functional domains are related to poor clinical outcome in non-small cell lung cancer patients. Clin. Cancer Res., 6: 1031-1037, 2000
16. Turnbull, R. B., Kyle, K., Watson, F. R., and Spratt, J. Cancer of the colon: The influence of no-touch isolation technique on survival rates. Ann. Surg., 166: 420-427, 1967
17. La Farina, M., Alberti, M., Russo, A., Bazan, V., Grasso, G., Romancino, D., Bazan, P., and Albanese, I. Optimization of RNA and DNA purification procedures from human colorectal carcinomas. Anticancer Res., 13: 1485-1488, 1993
18. Russo, A., Migliavacca, M., Bazan, V., Maturi, N., Morello, V., Dardanoni, G., Modica, G., Bazan, P., Albanese, I., La Farina, M., and Tomasino, R. M. Prognostic significance of proliferative activity. DNA-ploidy, p53 and ki-ras point mutations in colorectal liver metastases. Cell Prolif., 3: 139-153, 1998
19. Albanese, I., Rinaudo, C. D., Alberti, M., Bazan, V., Russo, A., Migliavacca, M., Bazan, P., Dardanoni, G., Tomasino, R. M., and La Farina, M. Ras and myc analysis in primary and metastatic colorectal carcinomas: Specific ras mutations are associated with Dukes'D stage and mucinous histotype. Int. J. Oncol., 10: 293, 1997
20. Russo, A., Bazan, V., Morello, V., Tralongo, V., Nagar, C., Nuara, R., Dardanoni, G., Bazan, P., and Tomasino, R. M. Vimentin expression, proliferating cell nuclear antigen and flow cytometric factors. Analyt. Quant. Cytol. Histol., 16: 365-374, 1994
21. Tomasino, R. M., Daniele, E., Bazan, V., Morello, V., Tralongo, V., Nuara, R., Nagar, C., Salvato, M., Ingria, F., Restivo, S., Dardanoni, G., Vecchione, A., and Russo A. Prognostic significance of cell kinetics in laryngeal squamous cell carcinoma: Clinicopathological associations. Cancer Res., 55: 6103-6108, 1995
22. Hiddemann, W., Schumann, J., Andreef, M., Barlogie, B., Herman, C. J., Leif, R. C., Mayall, B. H., Murphy, R. F., and Sandberg, A. A. Convention on nomenclature for DNA cytometry. Committee on Nomenclature, Society for Analytical Cytology. Cancer Genet. Cytogenet., 13: 181-183, 1984
23. Rabinovitch, P. S. Numerical compensation for the effects of the cell clumping on DNA histograms. Cytometry, 4(Suppl.): 27-30, 1990
24. Cox, D. R. Regression models and life tables. J. Am. Stat. Assoc., 34: 187-220, 1972
25. Overgaard, J., Yilmaz, M., Guldberg, P., Hansen, L. L., and Overgaard, J. TP53 mutation is an independent prognostic marker for poor outcome in both node-negative and node-positive breast cancer. Acta Oncol., 39: 327-333, 2000
26. Dix, B. R., Robbins, P., Soong, R., Jenner, D., House, A. K., and Iacopetta, B. J. The common molecular genetic alterations in Dukes' B and C colorectal carcinomas are not short-term prognostic indicators of survival. Int. J. Cancer, 59: 747-751, 1994
27. Hamelin, R., Laurent-Puig, P., Olschwang, S., Jego, N., Asselain, B., Remvikos, Y., Girodet, J., Salmon, R. J., and Thomas, G. Association of p53 mutations with short survival in colorectal cancer. Gastroenterology, 106: 42-48, 1994
28. Goh, H., Yao, J., and Smith, D. R. p53 point mutation and survival in colorectal cancer patients. Cancer Res., 55: 5217-5222, 1995
29. Bosari, S., Viale, G., Roncalli, M., Graziani, D., Borsani, G., Lee, A. K., and Coggi, G. p53 Gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma. Am. J. Pathol., 147: 790-798, 1995
30. Ross, J. S. DNA ploidy and cell cycle analysis in cancer diagnosis and prognosis. Oncology (Huntington), 10: 867-882, 1996
31. Quirke, P., Dyson, J. E., Dixon, M. F., Bird, C. C., and Joslin, C. A. Heterogeneity of colorectal adenocarcinomas evaluated by flow cytometry and histopathology. Br. J. Cancer, 51: 99-106, 1985
32. Flyger, H. L., Larsen, J. K., Nielsen, H. J., and Christensen, I. J. DNA ploidy in colorectal cancer, heterogeneity within and between tumors and relation to survival. Cytometry, 38: 293-300, 1999
33. Jernvall, P., Makinen, M., Karttunen, T., Makela, J., and Vihko, P. Conserved region mutations of the p53 gene are concentrated in distal colorectal cancers. Int. J. Cancer, 74: 97-101, 1997
34. Delattre, O., Olschwang, S., Law, D. J., Melot, T., Remvikos, Y., Salmon, R. J., Sastre, X., Validire, P., Feinberg, A. P., and Thomas, G. Multiple genetic alterations in distal and proximal colorectal cancer. Lancet, 2: 353-356, 1989
35. Meling, G. I., Lothe, R. A., Borresen, A. L., Graue, C., Hauge, S., Clausen, O. P., and Rognum, T. O. The TP53 tumour suppressor gene in colorectal carcinomas. Relation to DNA ploidy pattern and clinicopathological variables. Br. J. Cancer, 67: 93-98, 1993
36. Lanza, G., Gafa, R., Santini, A., Maestri, I., Dubini, A., Gilli, G., and Cavazzini, L. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma. Cancer (Phila.), 82: 49-59. 1998
37. Kim, H., Jen, J., Vogelstein, B., and Hamilton, S. R. Clinical and pathological characteristic of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Ann. J. Pathol., 145: 148-156, 1994
38. Beart, R. W., Melton, L. J., Ill, Maruta, M., Dockerty, M. B., Frydenberg, H. B., and O'Fallon, W. M. Trends in right- and left-sided colon cancer. Dis. Colon Rectum, 26: 393-398, 1983
39. Caldes, T., Iniesta, P., Vega, F. J., de Juan, C., Lopez, J. A., Diaz-Rubio, E., Fernandez, C., Cerdan, J., Balibrea, J. L., and Benito, M. Comparative survival analysis of p53 gene mutations and protein accumulation in colorectal cancer. Oncology, 55: 249-257, 1998
40. Kihara, C., Seki, T., Furukawa, Y., Yamana, H., Kimura, Y., van Schaardenburgh, P., Hirata, K., and Nakamura, Y. Mutations in zinc-binding domains of p53 as a prognostic marker of esophageal-cancer patients. Jpn. J. Cancer Res., 91: 190-198, 2000
41. Erber, R., Conradt, C., Homann, N., Enders, C., Finckh, M., Dietz, A., Weidauer, H., and Bosch, F. X. TP53 DNA contact mutations are selectively associated with allelic loss and have a strong clinical impact in head and neck cancer. Oncogene, 16: 1671-1679, 1998
42. Borresen, A. L., Andersen, T. I., Eyfjord, J. E., Cornelis, R. S., Thorlacius, S., Borg, A., Johansson, U., Theillet, C., Scherneck, S., and Hartman, S. TP53 mutations and breast cancer prognosis: Particularly poor survival rates for cases with mutations in the Zinc-binding domains. Genes Chromosomes Cancer, 14: 71-75, 1995
43. Huang, C., Kohno, N., Inufusa, H., Kodama, K., Taki, T., and Miyake, M. Overexpression of bax associated with mutation in the Loop-Sheet-Helix motif of p53. Am. J. Pathol., 155: 955-965, 1999
44. Wen, W. H., Reles, A., Runnebaum, I. B., Sullivan-Halley, J., Bernstein, L., Jones, L. A., Felix, J. C., Kreienberg, R., el-Naggar, A., and Press, M. F. p53 mutations and expression in ovarian cancers: Correlation with overall survival. Int. J. Gynecol. Pathol., 18: 29-41, 1999
45. Kimura, O., Sugamura, K., Kijima, T., Kurayoshi, K., Makino, M., and Kaibara, N. DNA index as a significant prognostic indicator of colorectal cancer. Gan To Kagaku Ryoho, 23(Suppl. 2): 118-124, 1996
46. Salud, A., Porcel, J. M., Raikundalia, B., Camplejohn, R. S., and Taub, N. A. Prognostic significance of DNA ploidy, S-phase fraction and P-glycoprotein expression in colorectal cancer. J. Surg. Oncol., 72: 167-174, 1999
47. Purdie, C. A., Piris, J. Histopathological grade, mucinous differentiation and DNA ploidy in relation to prognosis in colorectal carcinoma. Histopathology, 36: 121-126, 2000
48. Zarbo, R. J., Nakhleh, R. E., Brown, R. D., Kubus, J. J., Ma, C. K., Mackowiak, P. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry. Cancer (Phila.), 79: 2073-2078, 1997
49. Tonouchi, H., Matsumoto, K., Kinoshita, T., Itoh, H., and Suzuki, H. Prognostic value of DNA ploidy patterns of colorectal adenocarcinoma: Univariate and multivariate analysis. Dig. Surg., 15: 687-692, 1998